Skip to content

Here are 2 of the worst-timed congressional stock trades ever

Here are 2 of the worst-timed congressional stock trades ever
Elmaz Sabovic

Although U.S. Congress and Senate members are known for their well-timed and mostly profitable stock trades, some exceptions prove the rule, as with Senator Thomas Carper’s trade on August 29, 2023.

Namely, the Senator from Delaware purchased up to $15,000 worth of Innodata (NASDAQ: INOD) stock on August 29, 2023, when its price was $15 per share. 

Senator Carper's purchase of INOD stock. Source: Quiver Quantitative
Senator Carper’s purchase of INOD stock. Source: Quiver Quantitative

However, since then, INOD stock has experienced a 43% decline, falling to a valuation of $6.50 per share on March 21, 2024, when the Democrat Senator decided to offload his entire stake in Innodata for a loss of $8,500 on the trade, leaving him with $6,500 from his initial investment.

Senator Carper’s sale of INOD stock. Source: Quiver Quantitative
Senator Carper’s sale of INOD stock. Source: Quiver Quantitative

But what makes this trade even more ill-timed is that INOD stock has surged 165.85% since the sale.

INOD stock performance since Senator Carper's sale on March 21. Source: Google Finance
INOD stock performance since Senator Carper’s sale on March 21. Source: Google Finance

What caused the INOD stock surge?

Although a lesser-known stock, INOD is strongly connected to generative artificial intelligence (AI) and has benefited from the rally this sector experienced in 2024.

Innodata specializes in data collection for AI models, allowing it to expand its capabilities further. This made this company one of the first to start building databases for AI models, even before they became popular and highly profitable.

In its latest Q2 report, released on August 24, the company announced impressive financial results, where revenue reached $32.6 million, marking a 66% increase year-over-year. 

Additionally, it reported an adjusted EBITDA of $2.8 million, reflecting a 76% growth compared to the previous year. 

Based on this solid performance, Innodata has raised its guidance, projecting revenue growth of 60% or more for 2024.

If Carper were just a little more patient and decided to hold the stock for an entire year, his investment would now appreciate $17,280, for a profit of $2,280, thanks to Innodata’s strong Q2 performance.

Buy stocks now with eToro – trusted and advanced investment platform


Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.